# Ease Future

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ease-future

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.easefuture.com/
- Latest round: Series A (May 29, 2026)
- Investors on record: 4

## About

Founded in 2025 and based in Hangzhou, China, Hangzhou Ease Future Intelligent Technology Co., Ltd., trading as Ease Future, is a developer of AI-powered physical therapy robots. The company brings together elite talent from leading technology companies such as NetEase and Alibaba, as well as top universities like Peking University and Zhejiang University. Its core team possesses deep expertise in AI hardware, robot R&D, and commercialization. In May 2026, it closed a series A funding. Ease Future provides physical therapy robots integrated with AI. The robots are used in physical therapy and recovery treatment processes, including massage, magnetic shock waves, moxibustion, endogenous heat energy, fascia regeneration etc. The company generates revenue from sales of medical robot products and related service fees. The company will use the series A funding for three main areas: First, technological advancement, continuously tackling core underlying technologies such as human body perception and decision-making algorithms to build a strong data moat. Second, capacity expansion, upgrading the intelligent manufacturing system to ensure high-quality delivery and meet surging market demand. Third, market expansion, deepening the development of channels in lower-tier domestic markets while steadily advancing overseas expansion to create a world-class massage robot brand.

## Funding rounds

- Series A, May 29, 2026 — Cowin Capital, NetEase.com, Inc., Youshan Capital, HangZhou Capital
- Angel, Sep 4, 2025 — Cowin Capital

## Investors

- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Angel, Series A
- NetEase.com, Inc. — Series A
- Youshan Capital (https://capitalatlas.ai/funds/youshan-capital) — Series A
- HangZhou Capital (https://capitalatlas.ai/funds/hangzhou-capital) — Series A